DrugDashboards

Foster and Thrive Ready to Use Saline Laxative

SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM · SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mL · Enema · Rectal · McKesson

NDC 70677-1089-02 · 2 BOTTLE in 1 CARTON / 133 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.0070 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.0025$0.005$0.0075Aug 2024Sep 2026$0.007
23 price points · per MLSource: CMS NADAC

Medicaid spend (2025)

$3,596
307 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for sodium phosphate, dibasic, unspecified form and sodium phosphate, monobasic, unspecified form (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M007
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (Enema)

LabelerStrengthFirst seenLast seen
Alcyon Health, LLC.SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mLJul 15, 2026Sep 2, 2026
Dolgencorp, LLCSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mLJul 15, 2026Sep 2, 2026
Fred'sSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/133mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/133mLJul 15, 2026Sep 2, 2026
Leosons Overseas CorpSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 3.5 g/59mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 9.5 g/59mLJul 15, 2026Sep 2, 2026
Marc Glassman Inc.SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 19 g/133mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 7 g/133mLJul 15, 2026Sep 2, 2026
McKessonSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mLJul 15, 2026Sep 2, 2026
WalMartSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mLJul 15, 2026Sep 2, 2026
Chain Drug Marketing AssociationSODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Foster and Thrive Ready to Use Saline Laxative — NDC 70677-1089-02," retrieved September 3, 2026, https://drugdashboards.com/drug/70677108902.

Free to cite with attribution — see how the data is put together.